PROHANCE MULTIPACK Drug Patent Profile
✉ Email this page to a colleague
When do Prohance Multipack patents expire, and when can generic versions of Prohance Multipack launch?
Prohance Multipack is a drug marketed by Bracco and is included in one NDA.
The generic ingredient in PROHANCE MULTIPACK is gadoteridol. One supplier is listed for this compound. Additional details are available on the gadoteridol profile page.
Summary for PROHANCE MULTIPACK
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 34 |
Clinical Trials: | 9 |
Patent Applications: | 826 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROHANCE MULTIPACK at DailyMed |
Recent Clinical Trials for PROHANCE MULTIPACK
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Alabama at Birmingham | Early Phase 1 |
University of Alabama at Birmingham | Phase 1 |
GEHC (Sponsor) | Phase 4 |
Pharmacology for PROHANCE MULTIPACK
Drug Class | Paramagnetic Contrast Agent |
Mechanism of Action | Magnetic Resonance Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for PROHANCE MULTIPACK
US Patents and Regulatory Information for PROHANCE MULTIPACK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PROHANCE MULTIPACK
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | PROHANCE MULTIPACK | gadoteridol | INJECTABLE;INJECTION | 021489-001 | Oct 9, 2003 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PROHANCE MULTIPACK
See the table below for patents covering PROHANCE MULTIPACK around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S6452764 | 1-SUBSTITUTED 1,4,7-TRISCARBOXYMETHYL-1,4,7,10- TETRAAZACYCLODODECANE AND ANALOGUE | ⤷ Try a Trial |
European Patent Office | 0232751 | 1-SUBSTITUTED-4,7,10-TRISCARBOXYMETHYL-1,4,7,10-TETRAAZACYCLODODECANE AND ANALOGS | ⤷ Try a Trial |
Japan | 2537502 | ⤷ Try a Trial | |
Mexico | 174467 | 1,4,7-TRISCARBOXIMETIL-1,4,7,10-TETRAAZACICLODO DECANO SUBSTITUIDO EN 1 Y COMPUESTOS ANALOGOS | ⤷ Try a Trial |
Japan | S62190175 | 1-SUBSTITUTED-1,4,7-TRISCARBOXYMETHYL-1,4,7,10- TETRAAZACYCLODODECANE AND ANALOGUE | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |